Bloodstream infection in adults with sickle cell disease: Association with venous catheters, staphylococcus aureus, and bone-joint infections

Medicine

Volumn 85, Issue 1, 2006, Pages 43-48

  Zarrouk, Virginie ^a   Habibi, Anoosha ^a   Zahar, Jean Ralph ^a   Roudot Thoraval, Françoise ^a   Bachir, Dora ^a   Brun Buisson, Christian ^a   Legrand, Patrick ^a   Godeau, Bertrand ^a   Galacteros, Frédéric ^a   Lesprit, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BONE INFECTION; BONE NECROSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; INFECTIOUS ARTHRITIS; INTRAVENOUS CATHETER; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SICKLE CELL ANEMIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; ARTHROPATHY; BONE DISEASE; CATHETERIZATION; MICROBIOLOGY; PATHOGENICITY; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS;

ANTIINFECTIVE AGENT;

ADULT; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; BONE DISEASES; CATHETERIZATION, PERIPHERAL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; JOINT DISEASES; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33644936010     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000197023.46846.1c     Document Type: Article

References (28)

1. Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications. J Pediatr Hematol Oncol. 1995;127:685-690.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
3. Barett-Connor E. Bacterial infection and sickle cell anemia: an analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore). 1971;50:97-112.
4. Brun-Buisson C, Doyon F, Carlet J, and the French Bacteremia-Sepsis Study Group. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med. 1996;154:617-624.
5. Chung BH, Ha SY, Chan GC, Chiang A, Lee TL, Ho HK, Lee CY, Luk CW, Lau YL. Klebsiella infection in patients with thalassemia. Clin Infect Dis. 2003;36:575-579.
6. Communique du Comite de l'Antibiogramme de la Societe Francaise de Microbiologie (CASFM). Bulletin de la Societe Francaise de Microbiologie, 2002.
7. Epps CH Jr, Bryant DD 3rd, Coles MJ, Castro O. Osteomyelitis in patients who have sickle cell disease. Diagnosis and management. J Bone Joint Surg Am. 1991;73:1281-1294.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
9. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314:1593-1599.
10. Godeau B, Bachir D, Schaeffer A, Brun-Buisson C, Billy I, Portos JL, Galacteros F. Severe pneumococcal sepsis and meningitis in human immunodeficiency virus-infected adults with sickle cell disease. Clin Infect Dis. 1992;15:327-329.
11. Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle cell disease. J Bone Joint Surg Am. 2003;85-A:500-504.
12. Hord J, Byrd R, Stowe L, Windsor B, Smith-Whitley K. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24:470-472.
13. Jeng MR, Feusner J, Skibola C, Vichinsky E. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002;69:103-108.
14. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carso CA, Banerjee SN, Jarvis WR. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493-1499.
15. Magnus SA, Hambleton IR, Moosden F, Serjeant GR. Recurrent infections in homozygous sickle cell disease. Arch Dis Child. 1999;80:537-541.
16. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
17. McReady CE, Doughty HA, Pearson TC. Experience with the Port-A-Cath in sickle cell disease. Clin Lab Hematol. 1996;18:79-82.
18. Mollapour E, Porter JB, Kaczmarski R, Linch DC, Roberts PJ. Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A in sickle cell disease. Blood. 1998;91:3423-3429.
19. Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol. 2003;25:390-395.
20. Overturf GD. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis. 1999;14:191-218.
21. Perez P, Salmi LR, Follea G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R, for the BACHTEM Group and the French Haemovigilance Network. Determinants of transfusion-associated bacterial contamination: results of the French BACHTEM case-control study. Transfusion. 2001;47:862-872.
22. Perronne V, Roberts-Harewood M, Bachir D, Roudot-Thoraval F, Delord JM, Thuret I, Schaeffer A, Davies SC, Galacteros F, Godeau B. Patterns of mortality in sickle cell disease in France and England. J Haematol. 2002;3:56-60.
23. Phillips G, Slingluff C, Hartman J, Thomas P, Akwari O. Totally implantable intravenous catheters in the management of sickle cell anemia. Am J Hematol. 1988;29:134-138.
24. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
25. Powars D, Overturf G, Weiss J, Lee S, Chan L. Pneumococcal septicemia in children with sickle cell anemia. A changing trend of survival. JAMA. 1981;245:1839-1842.
26. Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vichinsky E, Wedgwood MJ. Immune response after splenectomy. Lancet. 1978;1:178-181.
27. Wagner SC, Eschelman DJ, Gonsalves CF, Bonn J, Sullivan KL. Infectious complications of implantable venous access devices in patients with sickle cell disease. J Vasc Interv Radiol. 2004;15:375-378.
28. Zarkowsky HS, Gallagher D, Gill FM, Wang WC, Falletta JM, Lande WM, Levy PS, Verter JI, Wethers D. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109:579-585.